DrugsControl Media Services

News Detail

US FDA warns AstraZeneca over misleading promotional materials for a COPD drug (17-08-2023)

Maryland, 16 Aug 2023: The Food and Drug Administration scolded AstraZeneca for making misleading claims about the effectiveness of a key medicine used treat chronic obstructive pulmonary disease.


In an Aug. 4 View Details

Source : STAT News & Fierce Pharma
AstraZeneca Breztri Aerosphere FDA FDA warning letter chronic obstructive pulmonary disease (COPD) Pharma Warning Letters Marketing Marketing

Related News